Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints
From MaRDI portal
Publication:5348691
DOI10.1002/bimj.201600047zbMath1422.62318OpenAlexW2593923038WikidataQ38927246 ScholiaQ38927246MaRDI QIDQ5348691
Axel Benner, Annette Kopp-Schneider, Christina Beisel, Christina Kunz
Publication date: 18 August 2017
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201600047
Linear regression; mixed models (62J05) Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Reliability and life testing (62N05)
Related Items
Cites Work
- Unnamed Item
- The asymptotic theory of permutation statistics.
- The frailty model.
- Sample-Size Formula for the Proportional-Hazards Regression Model
- Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification